Blog

Home - Blog

  • All Post
  • Fact Sheets
  • Feature
  • Frequently Asked Questions
  • Headlines
  • Testing
  • Treatment
  • Uncategorized

October 11, 2007/

Summary: The Fair Pricing Coalition and others are collecting signatures until this important Merck drug (the first integrase inhibitor) is approved and launched. —————————————- The Fair Pricing Coalition is asking Merck to price its new and very important integrase inhibitor at a level everyone can live with. The letter is…

February 20, 2007/

by John S. James Summary: How news feeds can advance biomedical research — as well as helping people follow specialized news. —————————————- A great challenge today is to help people find the key information they want and need, in the tsunami of new material that keeps coming out. Search engines…

February 20, 2007/

Summary: The inventor of the machine used to count T-cells, collect stem cells, and measure or collect many other rare cells was awarded the prestigious Kyoto Prize for advanced technology, at a ceremony in Japan. —————————————- Leonard Herzenberg, Ph.D., professor of genetics at Stanford University, received the Kyoto Prize, often…

February 20, 2007/

by John S. James Summary: During the first two weeks after release, prisoners in Washington State had 129 times the death rate from drug overdose, compared to other state residents — probably because they did not know how much less drug they could tolerate, after taking little or none of…

February 20, 2007/

Summary: The FDA added new drug-interaction warnings to the prescribing information for Sustiva (efavirenz). —————————————- On January 31 the FDA announced that the Sustiva (efavirenz) package insert had been changed “to include drug-drug interaction information regarding coadministration of efavirenz with rifampin, diltiazem, itraconazole, voriconazole, atorvastatin, pravastatin, simvastatin, pimozide and bepridil.”…

February 20, 2007/

Summary: The FDA changed the FUZEON prescribing information to help avoid this common and unpleasant side effect of the drug. —————————————- On January 31 the FDA announced that the FUZEON (enfuvirtide) package insert had been changed to include precautions to avoid injection-site reactions, either using a needle, or the Biojector(r)…

February 20, 2007/

Summary: Quick reference for telephone information. —————————————- For AIDS information (such as where to get tested, transmission, symptoms, news stories, or local AIDS organizations), try 1-800-CDC-INFO (1-800-232-4636), toll-free 24 hours a day in English or Spanish; when asked, select option ‘1’ to reach a person for health information. Trained operators…

Load More

End of Content.

Recent Posts

  • All Post
  • Fact Sheets
  • Feature
  • Frequently Asked Questions
  • Headlines
  • Testing
  • Treatment
  • Uncategorized

Emergency Call

Lorem Ipsum is simply dumy text of the printing typesetting industry beautiful worldlorem ipsum.

Categories


© 2024 Aids.org